Common menu bar links
A new technology that helps vaccines to "stick around" in the body could pave the way for effective vaccines against cancer. In fact, an experimental anti-cancer treatment delivered using the technology—called DepoVax™—has been shown to shrink tumours in mice.
This video shows MRI images of tumours in two mice—the first receives no vaccine; the second receives a vaccine delivered by DepoVax. Tumours are established in both cases, but shrink and disappear for the vaccinated group only.
For the full story, see Vaccine stays around, causes tumours to shrink.
Video length: 1:57 min
Important Notices
Video description
Mouse tumour challenge model MRI study
No vaccine – Week 0: Implant tumour
No vaccine – Week 1: Tumour established
No vaccine – Week 2: Tumour grows
No vaccine – Week 3: Large tumour
DepoVax eliminates established tumours
Week 0: Implant tumour
Week 1: Tumour established, Vaccine (DepoVax)
Week 2: Small tumour, DepoVax
Week 3: Tumour eliminated, active immune response
Mouse tumour ELIMINATED
Produced in collaboration with NRC Institute for Biodiagnostics
